Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Quertle Releases Qinsight — a Biomedical Literature Discovery Product Built on Its BioAI Artificial Intelligence Platform

Quertle LLC
Posted on: 26 Sep 16

Henderson, Nevada-based Quertle LLC, developer of the first artificial intelligence (AI) biomedical big data platform (BioAI™), has released Qinsight™. The product uses BioAI’s neural networks and other AI methods, along with predictive visual analytics, to enable high-efficiency discovery and insight from biomedical literature.

This Smart News Release features multimedia. View the full release here:

The visual analytics inQinsight™ provide summarization, discover emerging trends and uncover hidden connections. These capabilities overcome many of the problems of list-oriented results, which make information assimilation nearly impossible.

Qinsight™ covers more than 40 million documents, including searching the full text of more than 10 million. The content includes, essentially, all biomedical and biological journals, patent grants and applications, NIH grant applications, TOXLINE databases, AHRQ treatment protocols, and more, which, along with the AI underpinnings, gives a deeper perspective than that available anywhere else.

“Qinsight™, as the name implies, provides insight from the biomedical and life science literature that previously was elusive,” said Jeff Saffer, Quertle president and CEO. “We expect the combination of artificial intelligence-based discovery, along with intuitive visual analytics, to become critical to the success of the biomedical industry.”

Qinsight™ is available as a software as a service (SaaS) subscription, with both site licenses and individual user licenses available.


Quertle is a biomedical big data analytics company that has integrated artificial intelligence and other modern technologies into its platform to gain unmatched insight from biomedical and biological text content. The platform minimizes the risk of missing critical documents, providing an important resource for companies, university researchers and health care providers. In addition to Qinsight™, Quertle offers custom-built solutions based on the BioAI™ platform. Quertle boasts an extensive client list, which includes users at the top pharmas, research institutions, universities and hospitals. Quertle is a winner of the National Library of Medicine Innovation Challenge Award.

For more information about Quertle, visit

View source version on

Business Wire

Last updated on: 26/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.